Left Menu
Development News Edition

Chile keeps faith in Sinovac COVID-19 vaccine as Brazil data generates jitters elsewhere

He said vaccines would serve their critical purpose if they helped diminish severe symptoms, hospitalisations and deaths. This week, researchers in Brazil released late-stage trial clinical data showing the Sinovac vaccine was 50.4% effective at preventing symptomatic infections, including "very mild" cases.

Reuters | Updated: 15-01-2021 01:00 IST | Created: 15-01-2021 00:57 IST
Chile keeps faith in Sinovac COVID-19 vaccine as Brazil data generates jitters elsewhere
Representative image Image Credit: ANI

Chilean authorities said on Thursday they remained confident in a vaccine developed by China's Sinovac despite jitters elsewhere after researchers in Brazil acknowledged that its efficacy was lower than initially suggested.

Rodrigo Yanez, the Chilean trade undersecretary tasked with procuring COVID vaccines for the country, said Chile's health regulator was assessing all the available data and would announce its decision on an emergency roll-out for the inoculation soon. He said vaccines would serve their critical purpose if they helped diminish severe symptoms, hospitalisations and deaths.

This week, researchers in Brazil released late-stage trial clinical data showing the Sinovac vaccine was 50.4% effective at preventing symptomatic infections, including "very mild" cases. The previous week they said the vaccine, called CoronaVac, showed 78% efficacy against "mild-to-severe" cases. "The numbers in Brazil are good though they could be misleading in terms of focusing only on the 50% because the target is to avoid people filling the hospitals and fatalities," he told Reuters in a telephone interview. "It should be very effective with the more severe symptoms of the disease, provided that the clinical data supports what was announced this week."

Chile paid $3.5 million to host a clinical trial of the vaccine and has also ordered 60 million doses to be administered to its 18 mln-strong population over three years. The country's regulator sent two inspectors to the Sinovac factory in Beijing in November ahead of the expected arrival of the first doses in Chile in mid-January.

Chile has already started vaccinating its health workers using a Pfizer Inc developed shot and its regulator is also weighing approval of AstraZeneca's for emergency use. The disappointing Brazilian efficacy news prompted Malaysia and Singapore, which also have purchase agreements with Sinovac, to say on Wednesday that they would seek more data from the Chinese firm on efficacy rates before they approved and bought supplies.

Sinovac vaccination campaigns are however already underway in Indonesia and Turkey, with Turkish President Tayyip Erdogan receiving the jab on Thursday. Yanez told Reuters that the Chilean Public Health Institute would look at the data from Brazil as well as Turkey and Indonesia, which reported efficacy of 91.25% and 65.3% efficacy respectively based on interim trial data.

He said Sinovac's vaccine wasn't the only one which has raised doubts, pointing to experts in Australia who had questioned whether herd immunity could be achieved from the 62% efficacy reported for the AstraZeneca vaccine. "The common flu vaccine is between 50% and 60% effective – we run massive vaccination campaigns with those levels of efficacy," he said.

"We are in a position where we need to put a stop to the more severe impact of COVID-19. No vaccine so far is capable of proving that it also stops infections spreading, at the end of the day all of them are more or less efficient in helping you avoid the impact."

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

China stocks end higher on upbeat GDP data

China stocks ended higher on Monday, as investors cheered better-than-expected gross domestic product GDP data pointing to a strong recovery from the coronavirus crisis in the worlds second-largest economy. The blue-chip CSI300 index rose ...

No joint or coordinated parade this year at Attari border on Republic Day

This year, there will be no joint or coordinated parade at the Attari border on Republic Day. Earlier, Pakistan and India used to do a joint parade, which spectators used to watch from both the side. This year, no public will be allowed due...

BRIEF-AstraZeneca Says Enhertu Approved In The U.S. For Gastric Cancer

AstraZeneca PLC ASTRAZENECA PLC - ENHERTU APPROVED IN THE US FOR GASTRIC CANCER ASTRAZENECA - ENHERTU APPROVED IN US FOR TREATMENT OF PATIENTS WITH PREVIOUSLY TREATED HER2-POSITIVE ADVANCED GASTRIC CANCER Source text for Eikon Further compa...

4 Kerala MLAs test positive for COVID-19 after attending current session of Assembly

Thiruvananthapuram, Jan 18 PTI Four MLAs in Keralahave tested positive for COVID-19 after participating in theongoing session of the Assembly.The members representing Neyyattinkara, Kollam,Koyilandy and Peermedu--K Ansalan CPI-M, K Dasan CP...

Give Feedback